Edgewise Therapeutics Inc (EWTX) Company Profile & Statistics

Edgewise Therapeutics Inc
EWTX
(Nasdaq - US)
Open
32.59
+0.61 (+1.91%)
in:usd•As of: Nov 22, 2024 11:52 UTC -5
Open
32.47
High
32.59
Low
31.76

About Edgewise Therapeutics Inc

CEO

Kevin Koch

Headquarters

1715 38th st

boulder, co 80301, united states

Auditor

KPMG LLP

Employees

Share Holders

Website

www.edgewisetx.com

Industry

biotechnology

Sector

health technology

Company Overview

Edgewise Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on developing orally bioavailable, small molecule therapies for rare muscle disorders. Edgewise Therapeutics Inc. is based in Boulder, United States.

Edgewise Therapeutics Inc Statistics

Valuation Measures

Market Capitalization ²	3.09B
Enterprise Value	3.04B
Enterprise Value/EBITDA (ttm)	-19.36
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	6.04
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-26.83%
Return on Invested Capital (ttm)	-27.94%
Return on Assets (ttm)	-25.67%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-157.07M
Net Income Avi to Common (ttm)	-124.29M
Diluted EPS (ttm)	-1.50

Share Statistics

Beta (5Y Monthly)	0.14
52-Week Change	406.84%
S&P500 52-Week Change	30.73%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	94.69M
Dividend Yield	0.00%
Float ⁴	71.86M
% Held by Insiders	24.11%
% Held by Institutions	N/A

Balance Sheet

Total Cash (mrq)	492.54M
Total Cash Per Share (mrq)	5.20
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	26.35%
Quick Ratio (mrq)	26.35%
Book Value Per Share (mrq)	5.18

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.87
Free Cash Flow (ytd)	-83.11M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Edgewise Therapeutics Inc

Trade With A Regulated Broker